Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
315 participants
OBSERVATIONAL
2021-07-22
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes
NCT02428816
Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
NCT01888185
Non-invasive Diagnosis of Parkinson's Disease
NCT07201610
A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease
NCT00387075
Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes
NCT06155942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's disease
Clinically diagnosed Parkinson's disease
AIDP
Machine learning algorithm of imaging data
Multiple System Atrophy, Parkinsonian variant
Clinically diagnosed Multiple System Atrophy, Parkinsonian variant
AIDP
Machine learning algorithm of imaging data
Progressive Supranuclear Palsy
Clinically diagnosed Progressive Supranuclear Palsy
AIDP
Machine learning algorithm of imaging data
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AIDP
Machine learning algorithm of imaging data
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MSAp diagnosis
* PSP diagnosis
Exclusion Criteria
* claustrophobia
* pregnancy
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Augusta University
OTHER
Albany Medical College
OTHER
Beth Israel Deaconess Medical Center
OTHER
Duke University
OTHER
Johns Hopkins University
OTHER
Massachusetts General Hospital
OTHER
Northwestern University
OTHER
Ottawa Hospital Research Institute
OTHER
Penn State University
OTHER
University of Alabama at Birmingham
OTHER
University of California, San Diego
OTHER
University of California, San Francisco
OTHER
University of Chicago
OTHER
University of Michigan
OTHER
University of Minnesota
OTHER
University of South Florida
OTHER
Centre for Addiction and Mental Health
OTHER
Wake Forest University
OTHER
Washington University School of Medicine
OTHER
University of Kentucky
OTHER
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of California San Diego
La Jolla, California, United States
University of California San Francisco
San Francisco, California, United States
University of Florida
Gainesville, Florida, United States
University of South Florida
Tampa, Florida, United States
Augusta University
Augusta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
University of Kentucky
Lexington, Kentucky, United States
Johns Hopkins University
Lutherville, Maryland, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Massachusetts General Hospital
Charlestown, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
University of Minnesota
Minneapolis, Minnesota, United States
Washington University in St. Louis
St Louis, Missouri, United States
Albany Medical College
Albany, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
Wake Forest University
Winston-Salem, North Carolina, United States
Pennsylvania State University
Hershey, Pennsylvania, United States
Ottawa Hospital Research Institute
Ottawa, , Canada
Centre for Addiction and Mental Health
Toronto, , Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO00028349
Identifier Type: OTHER
Identifier Source: secondary_id
IRB202002350
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.